Pacific Biosciences Of California (PACB) Tax Provisions (2021 - 2026)

Pacific Biosciences Of California's Tax Provisions history runs 5 years deep, the most recent figure standing at $184000.0 for Q1 2026.

• In Q1 2026, Tax Provisions rose 160.93% year-over-year to $184000.0; the TTM figure through Mar 2026 stood at $804000.0 (up 5642.86% YoY), while the FY2025 annual figure was $318000.0, up 0.63% from the prior year.
• Tax Provisions was $184000.0 for Q1 2026 at Pacific Biosciences Of California, down from $202000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $383000.0 in Q3 2025 to a low of -$10.7 million in Q3 2023.
• Historically, Tax Provisions has averaged -$1.3 million across 4 years, with a median of $109500.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Tax Provisions sank 36.08% in 2025, then soared 160.93% in 2026.
• A 4-year view of Tax Provisions shows it stood at -$718000.0 in 2023, then jumped by 144.01% to $316000.0 in 2024, then slumped by 36.08% to $202000.0 in 2025, then retreated by 8.91% to $184000.0 in 2026.
• The last three Tax Provisions figures came in at $184000.0 (Q1 2026), $202000.0 (Q4 2025), and $383000.0 (Q3 2025), per Business Quant data.